Home

Paul B Manning

CIK 1494695 · last filed 2026-07-01

Paul B Manning is a corporate insider who has filed 77 SEC Form 4 insider transactions across 7 companies since 2016. The most recent filing, for CADL, was dated Jul 1, 2026. Across all open-market trades the lifetime net is +$75.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $167.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$167.71M

Companies

7

Total Filings

77

Lifetime Open-Market Net

$75.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CADL Director 2,984,752 $10.50 $31.34M $23.91M 13 2026-07-01
LQDA Director 911,139 $91.03 $82.94M -$24.24M 16 2026-06-18
VRCA Director 7,306,561 $5.12 $37.41M $48.04M 17 2025-11-25
TSHA Director 1,355,333 $6.37 $8.63M $25.15M 13 2025-06-03
ABOS 10%+ Owner 3,040,193 $2.43 $7.39M $5.00M 1 2021-07-08
Dova Pharmaceuticals Inc. (DOVA) Delisted Director 0 — — $7.34M 8 2019-11-12
AveXis, Inc. (AVXS) Delisted Director 0 — — -$10.00M 6 2018-05-15

Recent Filings

77 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 CADL Grant (A) — $0 EDGAR
2026-06-24 CADL Grant (A) — $0 EDGAR
2026-06-18 LQDA Grant (A) +5,882 $0 EDGAR
2026-06-08 LQDA Sell (S) −200,000 -$12.78M EDGAR
2026-06-04 LQDA Notice (144) −200,000 -$11.14M EDGAR
2026-04-02 CADL Grant (A) — $0 EDGAR
2026-02-26 CADL Buy (P) +550,458 $3.00M EDGAR
2026-02-12 LQDA Other (J) — $0 EDGAR
2025-11-25 VRCA Buy (P) +4,126,142 $17.51M EDGAR
2025-09-02 LQDA Sell (S) −670,837 -$18.96M EDGAR
Showing 1–10 of 77
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.